Pancreatic disease in 2014: Pancreatic fibrosis and standard diagnostics

Nature Reviews Gastroenterology and Hepatology

Volumn 12, Issue 2, 2015, Pages 68-70

  Ceyhan, Güralp O ^a   Friess, Helmut ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; SECRETIN; SONIC HEDGEHOG PROTEIN; VIMENTIN;

CARCINOGENESIS; CELL INFILTRATION; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; CYSTIC NEOPLASM; DIFFERENTIAL DIAGNOSIS; DIGITAL IMAGING; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVITY; FOXP3+ REGULATORY T LYMPHOCYTE; GOLD STANDARD; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MYOFIBROBLAST; OPEN STUDY; PANCREAS ADENOCARCINOMA; PANCREATIC STELLATE CELL; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; FIBROSIS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PATHOLOGY;

CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; FIBROSIS; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC;

EID: 84961296815     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.234     Document Type: Review

References (10)

1. Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461 (2009).
2. Larvol Delta. Infinity Pharma stops phase 2 trial of saridegib drug [online], http://delta.larvol.com/NewsItem/Default.aspx? NewsItemID=c7338a25-2790-4d02-ac1b-10582db5ec4b&ts=635474199797206000 (2012).
3. Ozdemir, B. C. et al. Depletion of carcinomaassociated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719-734 (2014).
4. Rhim, A. D. et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735-747 (2014).
5. Erkan, M. et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat. Rev. Gastroenterol. Hepatol. 9, 454-467 (2012).
6. Helm, O. et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE 9, e94357 (2014).
7. Shi, C. et al. Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophagestellate cell interaction. Lab. Invest. 94, 409-421 (2014).
8. Sherman, S. et al. Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis. Gastroenterology 147, 646-654 (2014).
9. Carbognin, G. et al. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. Radiol. Med. 114, 1214-1231 (2009).
10. Purysko, A. S. et al. Does secretin stimulation add to magnetic resonance cholangiopancreatography in characterising pancreatic cystic lesions as side-branch intraductal papillary mucinous neoplasm? Eur. Radiol. 24, 3134-3141 (2014).